PortalPublikationenLow prevalence of oral leukoplakia in a representative sampl...

Low prevalence of oral leukoplakia in a representative sample of the US population

Standard

Low prevalence of oral leukoplakia in a representative sample of the US population. / Scheifele, Christian; Reichart, Peter A; Dietrich, Thomas.

in: ORAL ONCOL, Jahrgang 39, Nr. 6, 01.09.2003, S. 619-25.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Scheifele, C, Reichart, PA & Dietrich, T 2003, 'Low prevalence of oral leukoplakia in a representative sample of the US population', ORAL ONCOL, Jg. 39, Nr. 6, S. 619-25. https://doi.org/10.1016/s1368-8375(03)00050-2

APA

Scheifele, C., Reichart, P. A., & Dietrich, T. (2003). Low prevalence of oral leukoplakia in a representative sample of the US population. ORAL ONCOL, 39(6), 619-25. https://doi.org/10.1016/s1368-8375(03)00050-2

Vancouver

Scheifele C, Reichart PA, Dietrich T. Low prevalence of oral leukoplakia in a representative sample of the US population. ORAL ONCOL. 2003 Sep 1;39(6):619-25. https://doi.org/10.1016/s1368-8375(03)00050-2

Bibtex

@article{9e13ffaf456e4cd3a5880eaf0d65330f,
title = "Low prevalence of oral leukoplakia in a representative sample of the US population",
abstract = "Recent studies reported a tendency towards a lower prevalence of oral leukoplakia (OL), compared with the past. To assess the prevalence of OL in a representative sample of the US population, data from the oral mucosal tissue assessment and some other covariates of 16128 participants in the US National Health and Nutrition Examination Survey (NHANES III) were included. The clinical definition of OL was applied according to the WHO criteria. The weighted prevalence estimates of OL were 0.66+/-0.14% in males, 0.21+/-0.05% in females and 0.42+/-0.08% in total. The age peaks were at 40-49 years in males and at >or=70 years in females. The prevalence estimates were 0.37% for homogeneous OL and 0.06% for non-homogeneous OL. Gingiva (38.8%) and buccal mucosa (30.9%) were the most frequent locations. Compared to previous studies in the USA, a substantial decline of the prevalence of OL was shown.",
keywords = "Adult, Age Distribution, Aged, Aged, 80 and over, Cheek, Chi-Square Distribution, Female, Health Surveys, Humans, Leukoplakia, Oral/epidemiology, Male, Middle Aged, Mouth Mucosa, Prevalence, Sex Distribution, United States/epidemiology",
author = "Christian Scheifele and Reichart, {Peter A} and Thomas Dietrich",
year = "2003",
month = sep,
day = "1",
doi = "10.1016/s1368-8375(03)00050-2",
language = "English",
volume = "39",
pages = "619--25",
journal = "ORAL ONCOL",
issn = "1368-8375",
publisher = "Elsevier Limited",
number = "6",

}

RIS

TY - JOUR

T1 - Low prevalence of oral leukoplakia in a representative sample of the US population

AU - Scheifele, Christian

AU - Reichart, Peter A

AU - Dietrich, Thomas

PY - 2003/9/1

Y1 - 2003/9/1

N2 - Recent studies reported a tendency towards a lower prevalence of oral leukoplakia (OL), compared with the past. To assess the prevalence of OL in a representative sample of the US population, data from the oral mucosal tissue assessment and some other covariates of 16128 participants in the US National Health and Nutrition Examination Survey (NHANES III) were included. The clinical definition of OL was applied according to the WHO criteria. The weighted prevalence estimates of OL were 0.66+/-0.14% in males, 0.21+/-0.05% in females and 0.42+/-0.08% in total. The age peaks were at 40-49 years in males and at >or=70 years in females. The prevalence estimates were 0.37% for homogeneous OL and 0.06% for non-homogeneous OL. Gingiva (38.8%) and buccal mucosa (30.9%) were the most frequent locations. Compared to previous studies in the USA, a substantial decline of the prevalence of OL was shown.

AB - Recent studies reported a tendency towards a lower prevalence of oral leukoplakia (OL), compared with the past. To assess the prevalence of OL in a representative sample of the US population, data from the oral mucosal tissue assessment and some other covariates of 16128 participants in the US National Health and Nutrition Examination Survey (NHANES III) were included. The clinical definition of OL was applied according to the WHO criteria. The weighted prevalence estimates of OL were 0.66+/-0.14% in males, 0.21+/-0.05% in females and 0.42+/-0.08% in total. The age peaks were at 40-49 years in males and at >or=70 years in females. The prevalence estimates were 0.37% for homogeneous OL and 0.06% for non-homogeneous OL. Gingiva (38.8%) and buccal mucosa (30.9%) were the most frequent locations. Compared to previous studies in the USA, a substantial decline of the prevalence of OL was shown.

KW - Adult

KW - Age Distribution

KW - Aged

KW - Aged, 80 and over

KW - Cheek

KW - Chi-Square Distribution

KW - Female

KW - Health Surveys

KW - Humans

KW - Leukoplakia, Oral/epidemiology

KW - Male

KW - Middle Aged

KW - Mouth Mucosa

KW - Prevalence

KW - Sex Distribution

KW - United States/epidemiology

U2 - 10.1016/s1368-8375(03)00050-2

DO - 10.1016/s1368-8375(03)00050-2

M3 - SCORING: Journal article

C2 - 12798406

VL - 39

SP - 619

EP - 625

JO - ORAL ONCOL

JF - ORAL ONCOL

SN - 1368-8375

IS - 6

ER -